Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Post by DCFruleson May 17, 2021 4:25pm
166 Views
Post# 33215994

Improved FCF

Improved FCFI agree that Aleafia’s financial performance has been a disaster. However, one minor positive aspect that has gone unnoticed is that Aleafia’s free cash flow (FCF) improved slightly in Q1, although still negative. This is worth mentioning because a stock’s intrinsic value is driven primarily by the anticipated future generation of positive FCFs. Aleafia’s historic FCFs generated in 2020 Q2, Q3 and Q4 and 2021 Q1 are -$16.1M, -$10.4M, -$10.1M and -$7.1M respectively. Although this represents a slight improvement, Aleafia needs to generate positive FCFs and quickly.
Intrinsic value obviously depends on the FCF forecast used. For analysis purposes, I generated 8 FCF forecasts and applied a simplified FCF valuation technique. Aleafia’s intrinsic value per share ranged from $0.24 to $2.36 depending on which FCF forecast one is comfortable with. The concept of FCF, the simplified FCF valuation technique and my eight FCF forecasts, calculations and assumptions are described on my website:
 https://www.npvguide.com/valuing-aleafia-health-inc/

<< Previous
Bullboard Posts
Next >>